Bionovate Technologies Cash Flow Statement

Financials in millions USD. Fiscal year is July - June.

Millions USD. Fiscal year is Jul - Jun.

Fiscal Year	TTM	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Sep '21 Sep 30, 2021	Jun '21 Jun 30, 2021	Jun '20 Jun 30, 2020	Jun '19 Jun 30, 2019	Jun '18 Jun 30, 2018	Jun '17 Jun 30, 2017
Net Income	-0.11	-0.11	-0.12	-0.21	-1.74	-0.32
Other Amortization	-	-	0.03	0.1	0.05	0.05
Loss (Gain) From Sale of Assets	-	-	-	-	-	-0.03
Asset Writedown & Restructuring Costs	-	-	-	-	0.02	0.23
Other Operating Activities	0.05	0.05	0.03	0.04	1.56	0.01
Change in Accounts Payable	0.06	0.05	0.07	0.07	0.04	0.01
Change in Other Net Operating Assets	-	-	-	-	0.07	0.07
Operating Cash Flow	-	-	-	-	-	0.01
Operating Cash Flow Growth	-	-	-	-	-	2371.79%
Cash Acquisitions	-	-	-	-	-	0
Divestitures	-	-	-	-	-	-0
Other Investing Activities	-	-	-	-	-	0
Investing Cash Flow	-	-	-	-	-	0.01
Short-Term Debt Issued	-	-	-	-	-	0.01
Total Debt Issued	-	-	-	-	-	0.01
Net Debt Issued (Repaid)	-	-	-	-	-	0.01
Repurchase of Common Stock	-	-	-	-	-	-0.02
Financing Cash Flow	-	-	-	-	-	-0.02
Foreign Exchange Rate Adjustments	-	-	-	-	-	-0
Net Cash Flow	-	-	-	-	-	-0
Change in Working Capital	0.06	0.05	0.07	0.07	0.11	0.08

Source: S&P Global Market Intelligence. Standard template. Financial Sources.